Significant Incidental Findings on Low-Dose CT Linked to Increased Risk for Extrapulmonary Cancer Diagnosis
Medically reviewed by Drugs.com
via HealthDayTHURSDAY, April 9, 2026 -- Cancer significant incidental findings (SIF) not related to lung cancer reported in patients undergoing lung cancer screening with low-dose computed tomography (LDCT) are associated with an increased risk for an extrapulmonary cancer diagnosis in the year following screening, according to a study published online March 31 in JAMA Network Open.
Ilana F. Gareen, Ph.D., from the Brown University School of Public Health in Providence, Rhode Island, and colleagues conducted a retrospective cohort study analyzing data from National Lung Screening Trial participants who were randomly assigned to LDCT or chest radiography to examine the association between an SIF considered to be potentially indicative of extrapulmonary cancer detected at LDCT screening and diagnosis of extrapulmonary cancer within one year. A total of 75,104 LDCT screening rounds performed in 26,445 participants were included in the study.
The researchers found that across the three rounds of screening, cancer SIFs were reported for 2,265 screening rounds (3.0 percent) in 1,807 participants (6.8 percent). For 67 participants (3.0 percent), an extrapulmonary cancer was diagnosed following a screening round with a cancer SIF. After covariates and participant-specific adjustments, the marginal risk difference was 13.89 per 1,000 participants. Urinary cancers and other Surveillance, Epidemiology, and End Results cancer categories, including lymphoma and leukemia, had significantly higher marginal risk differences (17.03 and 13.83 per 1,000 participants, respectively).
"In this paper, we provide an evidence base for making decisions on abnormalities outside of the lungs that might be seen at lung screening," Gareen said in a statement.
One author disclosed ties to Arnold Ventures.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-04-10 01:59
Read more
- ACC: Hypertensive Heart Disease Mortality Increasing in Young Women
- Pfizer and Valneva Announce Lyme Disease Vaccine Candidate PF-07307405 (LB6V) Demonstrates Strong Efficacy in Phase 3 VALOR Trial
- Laser Red-Light Therapy Delivers Irradiance Levels Exceeding Safety Limits
- Argo Biopharma Receives FDA Fast Track Designation for BW-20805, an Investigational siRNA Therapy for the Treatment of HAE
- NIH Researchers Discover Pain-Relieving Drug with Minimal Addictive Properties
- Move Over, Cigarettes: Vapes Now the Leading Nicotine Danger for Kids
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions